ADRB2 and obstructive sleep apnea syndrome: Also in this regard, the exploration and characterization of other β-blockers in OSA, especially selective β antagonists (i.e. Metoprolol for ADRB1 or ICI 118,551 for ADRB2) would be highly interesting from a mechanistically point of view.